Please login to the form below

Not currently logged in
Email:
Password:

Prosena Therapeutics

This page shows the latest Prosena Therapeutics news and features for those working in and with pharma, biotech and healthcare.

GSK's muscular dystrophy drug 'a breakthrough' says FDA

GSK's muscular dystrophy drug 'a breakthrough' says FDA

Holland-based Prosensa and GSK are currently in a race with Sarepta Therapeutics of the US (formerly AVI BioPharma) to bring an exon 51-skipping drug for DMD to market, and

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Larry Bell joins Dutch biopharma Prosensa Larry Bell joins Dutch biopharma Prosensa

    Takes up role as head of global regulatory affairs. Dutch biopharmaceutical company Prosensa Therapeutics has appointed Larry Bell as head of global regulatory affairs. ... For his new role at Prosensa, which focuses on RNA-modulating therapeutics for

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
The Good Ideas Group

Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...

Latest intelligence

How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....